| Literature DB >> 34195138 |
Chintha Sujatha1, Reshma R Sudha2, Anish T Surendran1, Aravind Reghukumar3, Mathew J Valamparampil4, Indu P Sathyadas1,5, Prajitha K Chandrasekharan1.
Abstract
BACKGROUND AND OBJECTIVES: The morbidity and mortality spectrum of the south Indian state of Kerala is dominated by chronic non-communicable diseases, yet febrile illnesses because of neglected tropical diseases and emerging viral infections are often reported. As fever deaths are mostly avoidable, understanding the determinants of mortality is essential for implementing preventive measures.Entities:
Keywords: Dengue; Fever Mortality; Kerala; Risk Factors; Social and health system determinants
Year: 2021 PMID: 34195138 PMCID: PMC8208210 DOI: 10.4103/jfmpc.jfmpc_2434_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Socio-demographic factors and Personal history
| Variables | Cases (36) | Controls (72) | OR (95%CI) | |
|---|---|---|---|---|
| Age >40 years | 20 (55.6) | 21 (29.2) | 3.03 (1.32-6.96) | 0.008 |
| Gender | ||||
| Male | 19 (52.8) | 27 (37.5) | 1.86 (0.83-4.19) | 0.13 |
| Socioeconomic status# | ||||
| Low SES | 15 (41.7) | 35 (48.6) | 0.75 (0.33-1.69) | 0.49 |
| Place of residence | ||||
| Rural | 17 (47.2) | 46 (63.9) | 0.51 (0.22-1.14) | 0.098 |
| Education status | ||||
| Secondary or less | 18 (50) | 35 (48.6) | 1.05 (0.47-2.35) | 0.892 |
| Occupation status | ||||
| Semiskilled or less | 17 (47.2) | 50 (69.4) | 0.39 (0.17-0.89) | 0.025 |
| Health insurance | ||||
| Available | 17 (47.2) | 44 (61.1) | 0.56 (0.25-1.27) | 0.170 |
| Type of Health Insurance | ||||
| Government Medical insurance | 14 (77.8) | 38 (86.4) | Not calculated | 0.674 |
| Private medical insurance | 1 (5.6) | 2 (4.5) | ||
| Other social insurance | 3 (16.7) | 4 (9.1) | ||
| Tobacco Smoking | ||||
| Present | 8 (22.2) | 7 (9.7) | 2.65 (0.87-8.02) | 0.07 |
| Alcohol use | ||||
| Present | 11 (30.6) | 10 (13.9) | 2.72 (1.03-7.22) | 0.039 |
| Built | ||||
| Thin | 0 (0) | 4 (5.6) | Not calculated | 0.031 |
| Moderate | 32 (88.9) | 67 (93.1) | ||
| Heavy | 4 (11.1) | 1 (1.4) | ||
| Diabetes mellitus | ||||
| Present | 10 (27.8) | 11 (15.3) | 2.13 (0.80-5.63) | 0.122 |
| Hypertension | ||||
| Present | 5 (13.9) | 12 (16.7) | 0.80 (0.26-2.49) | 0.709 |
| Cardio Vascular Disease | ||||
| Present | 2 (5.6) | 2 (2.8) | 2.05 (0.27-15.24) | 0.471 |
| Chronic lung disease | ||||
| Present | 6 (16.7) | 5 (6.9) | 2.68 (0.75-9.47) | 0.115 |
| H/o dengue | ||||
| Present | 2 (5.9) | 7 (9.9) | 0.57 (0.11-2.91) | 0.496 |
| Family members reported to be affected by Dengue | ||||
| Yes | 10 (29.4) | 20 (28.2) | 1.06 (0.43-2.61) | 0.89 |
*P<0.05 considered significant, obtained from Chi square test. #As ascertained by government criteria of above and below poverty line
Health seeking, access and utilization of health care
| Variable | Frequency, | OR (95%CI) | ||
|---|---|---|---|---|
| Cases (36) | Controls (72) | |||
| Self-medication | ||||
| Present | 12 (33.3) | 11 (15.3) | 2.77 (1.07-7.13) | 0.031 |
| Oral fluid intake before hospitalization | ||||
| Adequate | 18 (51.4) | 56 (77.8) | 0.30 (0.12-0.71) | 0.006 |
| Bed rest before hospitalization | ||||
| Adequate | 20 (57.1) | 59 (81.9) | 0.29 (0.12-0.72) | 0.006 |
| Treatment initiated from | ||||
| Govt sector hospital | 17 (47.2) | 50 (69.4) | 0.39 (0.17-0.89) | 0.025 |
| System of medicine from where treatment was initiated | ||||
| Modern medicine | 34 (94.4) | 69 (95.8) | Not calculated | 0.286 |
| Ayurveda | 2 (5.6) | 1 (1.4) | ||
| Homeopathy | 0 | 2 (2.8) | ||
| Reason for choosing health facility | ||||
| Nearby | 11 (30.6) | 55 (76.4) | <0.001 | |
| Good doctor | 4 (11.1) | 5 (6.9) | ||
| Good facility | 6 (16.7) | 9 (12.5) | ||
| Routine | 15 (41.7) | 3 (4.2) | ||
| Distance of health facility from home (in kms) | 3.6 (1.6) | 2.9 (1.5) | 0.036 | |
| Time gap between onset of symptoms and first medical consultation (in days) | 2.4 (1.2) | 1.5 (0.8) | <0.001 | |
| Time gap between onset of symptoms and final diagnosis (in days) | 6.5 (3.0) | 4.3 (1.7) | <0.001 | |
| Time gap between onset of symptoms and terminal event (in days) | 11.2 (6.1) | 9.7 (3.7) | 0.196 | |
| Number of consultations till final diagnosis | 2 (0.7) | 1.6 (0.7) | 0.017 | |
| Total number of consultations | 2.7 (0.7) | 2.4 (0.7) | 0.066 | |
| Duration of symptoms at time of admission (in days) | 5.2 (1.9) | 4.3 (1.4) | 0.004 | |
| Total duration of hospital stay (in days) | 6.1 (5.8) | 5.7 (3.6) | 0.775 | |
| Field health workers visited in last two months | 12 (33.3) | 36 (50) | 0.50 (0.22-1.15) | 0.100 |
| Information on preventive measures given by authorities | 10 (27.8) | 33 (45.8) | 0.45 (0.19-1.07) | 0.071 |
*P<0.05 considered significant, obtained from Chi square test and independent sample t-test
Clinical presentation and Complications
| Variable | Cases (36) | Controls (72) | OR (95% CI) | |
|---|---|---|---|---|
| Fever | 35 (97.2) | 71 (98.6) | 0.49 (0.03-8.11) | 0.614 |
| Headache | 14 (38.9) | 44 (61.1) | 0.41 (0.18-0.92) | 0.029 |
| Myalgia | 21 (58.3) | 49 (68.1) | 0.65 (0.28-1.50) | 0.319 |
| Fatigue | 22 (61.1) | 43 (59.7) | 1.06 (0.46-2.40) | 0.889 |
| Vomiting | 18 (50) | 49 (68.1) | 0.47 (0.21-1.06) | 0.068 |
| Abdominal pain | 10 (27.8) | 32 (44.4) | 0.48 (0.20-1.14) | 0.094 |
| Loose stools | 10 (27.8) | 9 (12.5) | 2.69 (0.98-7.39) | 0.049 |
| Cough | 14 (38.9) | 9 (12.5) | 4.45 (1.69-11.72) | 0.002 |
| Breathlessness | 28 (77.8) | 10 (13.9) | 21.7 (7.73-60.85) | <0.001 |
| Chest discomfort | 11 (30.6) | 3 (4.2) | 10.12 (2.61-39.27) | <0.001 |
| Palpitation | 5 (13.9) | 1 (1.4) | 11.45 (1.28-10.12) | 0.008 |
| Restlessness | 19 (52.8) | 2 (2.8) | 39.12 (8.29-108.37) | <0.001 |
| Jaundice | 12 (33.3) | 1 (1.4) | 35.50 (4.38-128.54) | <0.001 |
| Oliguria | 7 (19.4) | 2 (2.8) | 8.44 (1.65-43.12) | 0.003 |
| Drowsiness | 23 (63.9) | 7 (9.7) | 16.43 (5.84-46.23) | <0.001 |
| Altered consciousness | 15 (41.7) | 4 (5.6) | 12.14 (3.63-40.58) | <0.001 |
| Seizures | 8 (22.2) | 0 | <0.001 | |
| Abnormal reflexes | 4 (11.1) | 0 | 0.004 | |
| Skin bleed | 5 (13.9) | 3 (4.2) | 3.71 (0.83-16.51) | 0.069 |
| Epistaxis | 3 (8.3) | 2 (2.8) | 3.18 (0.51-19.96) | 0.195 |
| Gum bleeding | 6 (16.7) | 6 (8.3) | 2.20 (0.65-7.39) | 0.194 |
| Hemoptysis | 1 (2.8) | 1 (1.4) | 2.03 (0.12-33.4) | 0.614 |
| Hematemesis | 1 (2.8) | 3 (4.2) | 0.66 (0.06-6.55) | 0.719 |
| Malena | 5 (13.9) | 12 (16.7) | 0.81 (0.26-2.49) | 0.709 |
| Increased menstrual flow than usual | 1 (2.8) | 5 (6.9) | 0.38 (0.04-3.41) | 0.373 |
| Intracranial bleed | 4 (11.1) | 0 | 0.004* | |
| Hypotension | 19 (52.8) | 1 (1.4) | 79.5 (9.92-193.76) | <0.001* |
| Abdominal tenderness | 9 (25) | 7 (9.7) | 3.09 (1.05-9.15) | 0.035* |
| Edema | 9 (25) | 3 (4.2) | 7.67 (1.92-30.48) | 0.001* |
| Ascites | 4 (11.1) | 3 (4.2) | 2.87 (0.61-13.61) | 0.167 |
| Pleural effusion | 6 (16.7) | 3 (4.2) | 4.60 (1.08-19.62) | 0.027* |
| Hemorrhagic syndrome | 8 (22.2) | 3 (4.2) | 6.57 (1.62-26.58) | 0.003 |
| Shock | 12 (33.3) | 0 | 4 (2.28-5.65) | <0.001 |
| Disseminated Intravascular Coagulation (DIC) | 5 (13.9) | 0 | 3.32 (2.47-4.46) | 0.001 |
| Expanded dengue syndrome | 21 (58.3) | 4 (5.6) | 23.8 (7.12-79.54) | <0.001 |
| Acute Respiratory Distress Syndrome (ARDS) | 23 (63.9) | 1 (1.4) | 12.6 (15.5-101.1) | <0.001 |
| Acute kidney injury | 15 (41.7) | 1 (1.4) | 50.71 (6.3-80.7) | <0.001 |
| Hepatitis | 13 (36.1) | 21 (29.2) | 1.37 (0.58-3.21) | 0.464 |
| Myocarditis | 12 (33.3) | 3 (4.2) | 11.5 (2.99-44.26) | <0.001 |
| Polyserositis | 5 (13.9) | 3 (4.2) | 3.71 (0.83-16.50) | 0.114 |
| Encephalitis | 6 (16.7) | 2 (1.4) | 14.2 (1.64-42.08) | 0.002 |
| Pancreatitis | 2 (5.6) | 1 (1.4) | 4.18 (0.36-47.68) | 0.214 |
| Multi Organ Dysfunction Syndrome (MODS) | 15 (41.7) | 1 (1.4) | 50.71 (6.3-98.7) | <0.001 |
*P<0.05 considered significant, obtained from Chi square test
Laboratory parameters
| Variable | Cases (36) | Controls (72) | OR (95%CI) | |
|---|---|---|---|---|
| WBC Count per μl | ||||
| More than 10,000 | 8 (22.2) | 4 (5.6) | 4.85 (1.3-17.4) | 0.009 |
| Serum Albumin (g/dL) | ||||
| 3 or less | 14 (38.9) | 13 (18.1) | 2.89 (1.1-7.1) | 0.018 |
| ALT (units/L) | ||||
| More than 300 | 12 (33.3) | 10 (13.9) | 3 (1.18-8.11) | 0.018 |
| AST (units/L) | ||||
| More than 300 | 13 (36.1) | 10 (13.9) | 3.5 (1.35-9.01) | 0.008 |
| Blood Urea (mg/dL) | ||||
| More than 50 | 16 (44.4) | 2 (2.8) | 28 (5.9-132.1) | <0.001 |
| Serum Creatinine (mg/dL) | ||||
| More than or equal to 2 | 11 (30.6) | 1 (1.4) | 31.2 (3.8-94.4) | <0.001 |